- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04490278
CoV-PICS: A Virtual Post-ICU Clinic
COVID-19 Virtual Post Intensive Care Syndrome (CoV-PICS) Clinic: Modern, Convenient and Practical Recovery Care
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110
- Washington University School of Medicine/Barnes-Jewish Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 years of age or older
- COVID-19 diagnosis with a stay in the ICU.
- A home internet connection or smartphone access, along with the ability to use them
- Missouri resident
Exclusion Criteria:
- Severe cognitive deficits or dementia prior to hospitalization
- Long-term resident of a skilled nursing facility prior to admission
- Non-English speaking (will not have an interpreter available)
- Hospice or Comfort Care at discharge
- No plans to return to some degree of independent living at the time of discharge
- Pregnant at the time of discharge
- Prisoner at the time of discharge
- Blind
- Deaf
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Patients with PICS
|
Patient characteristics, medical history, and information regarding their inpatient treatment from the electronic medical record
Patients will complete online questionnaires related to their physical, cognitive and mental health function and inquire about current treatments.
The multiprofessional CoV-PICS clinic practitioners will evaluate their responses and, combined with information obtained during their virtual visits, formulate a suggested treatment plan and needed referrals.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acceptance With COVID-19 Virtual Post Intensive Care Syndrome (CoV-PICS) Visits - AIM
Time Frame: up to 6 months after consent
|
Acceptability of Intervention Measure (AIM) Implementation of outcome measure.
Response Scale: 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree
|
up to 6 months after consent
|
Acceptance With COVID-19 Virtual Post Intensive Care Syndrome (CoV-PICS) Visits - IAM
Time Frame: up to 6 months after consent
|
Intervention Appropriateness Measure (IAM) Implementation of outcome measure.
Response Scale: 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree
|
up to 6 months after consent
|
Acceptance With COVID-19 Virtual Post Intensive Care Syndrome (CoV-PICS) Visits - FIM
Time Frame: up to 6 months after consent
|
Feasibility of Intervention Measure (FIM) Implementation of outcome measure.
Response Scale: 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree
|
up to 6 months after consent
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post Intensive Care Syndrome (PICS) Symptoms - Daily Living - Visit 1
Time Frame: Up to 6 months after consent
|
Katz Independence in Activities in Daily Living Rates daily activities by independence or dependence in completing the task (range 0-6) 0=low or patient very dependent, 6 = high or patient independent
|
Up to 6 months after consent
|
Post Intensive Care Syndrome (PICS) Symptoms - Daily Living - Visit 2
Time Frame: Approximately 60 days after initial visit (scheduling dependent)
|
Katz Independence in Activities in Daily Living Rates daily activities by independence or dependence in completing the task (range 0-6) 0=low or patient very dependent, 6 = high or patient independent
|
Approximately 60 days after initial visit (scheduling dependent)
|
Post Intensive Care Syndrome (PICS) Systems - Cognitive Visit 1
Time Frame: Up to 6 months after consent
|
Montreal Cognitive Assessment (MoCA) Screening tool for mild cognitive dysfunction.
Scores range from 0 to 15 with scores of 11 and above considered normal and below 11 considered cognitive impairment.
|
Up to 6 months after consent
|
Post Intensive Care Syndrome (PICS) Systems - Cognitive Visit 2
Time Frame: Approximately 60 days after initial visit (scheduling dependent)
|
Montreal Cognitive Assessment (MoCA) Screening tool for mild cognitive dysfunction.
Scores range from 0 to 15 with scores of 11 and above considered normal and below 11 considered cognitive impairment
|
Approximately 60 days after initial visit (scheduling dependent)
|
Post Intensive Care Syndrome (PICS) Systems - Nutrition Initial Visit
Time Frame: Up to 6 months after consent
|
Scored Patient-Generated Subjective Global Assessment (PG-SGA) The Scored PG-SGA© includes the four patient-generated historical components (Weight History, Food Intake, Symptoms and Activities and Function - also known as the PG-SGA Short Form©), the professional part, the Global Assessment, the total numerical score (0-1 No risk, 2-3 Mild risk, 4-8 Moderate risk, 9 or more High risk), and nutritional triage recommendations based on the score. For each component of the PG-SGA, points (0-4) are awarded depending on the impact on nutritional status. Typical scores range from 0-35 with a higher score reflecting a greater risk of malnutrition and scores ≥9 indicating a critical need for nutrition intervention and symptom management 0-1: no intervention 2-3: patient and family education by dietician or nurse 4-8: requires intervention by dietician >9: critical need for symptom intervention |
Up to 6 months after consent
|
Post Intensive Care Syndrome (PICS) Systems - Nutrition Final Visit
Time Frame: Approximately 60 days after initial visit (scheduling dependent)
|
Scored Patient-Generated Subjective Global Assessment (PG-SGA) The Scored PG-SGA© includes the four patient-generated historical components (Weight History, Food Intake, Symptoms and Activities and Function - also known as the PG-SGA Short Form©), the professional part, the Global Assessment, the total numerical score (0-1 No risk, 2-3 Mild risk, 4-8 Moderate risk, 9 or more High risk), and nutritional triage recommendations based on the score. For each component of the PG-SGA, points (0-4) are awarded depending on the impact on nutritional status. Typical scores range from 0-35 with a higher score reflecting a greater risk of malnutrition and scores ≥9 indicating a critical need for nutrition intervention and symptom management 0-1: no intervention 2-3: patient and family education by dietician or nurse 4-8: requires intervention by dietician >9: critical need for symptom intervention |
Approximately 60 days after initial visit (scheduling dependent)
|
Post Intensive Care Syndrome (PICS) Symptoms - Memory
Time Frame: up to 6 months after consent
|
ICU Memory Tool (all inclusive tool that measures multiple items as described below) Questionnaire of patient's memory and feelings of ICU stay. Outcomes reported as the total number of memory types per group: factual memories, memories of feelings, delusional memories, unexplained feelings of panic, intrusive memories. |
up to 6 months after consent
|
Collaborators and Investigators
Investigators
- Principal Investigator: Chris Palmer, MD, Washington University School of Medicine
Publications and helpful links
General Publications
- Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648. No abstract available.
- Sommer P, Lukovic E, Fagley E, Long DR, Sobol JB, Heller K, Moitra VK, Pauldine R, O'Connor MF, Shahul S, Nunnally ME, Tung A. Initial Clinical Impressions of the Critical Care of COVID-19 Patients in Seattle, New York City, and Chicago. Anesth Analg. 2020 Jul;131(1):55-60. doi: 10.1213/ANE.0000000000004830.
- Rawal G, Yadav S, Kumar R. Post-intensive Care Syndrome: an Overview. J Transl Int Med. 2017 Jun 30;5(2):90-92. doi: 10.1515/jtim-2016-0016. eCollection 2017 Jun.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202007053
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post ICU Syndrome
-
Tulane University School of MedicineThe Arnold P. Gold FoundationCompleted
-
Medical Centre LeeuwardenRecruitingICU Acquired Weakness | Post-Intensive Care SyndromeNetherlands
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Dutch...Recruiting
-
Oslo University HospitalCompletedPost Traumatic Stress Symptoms | Post ICU PatientNorway
-
Romain RonfleCompletedQuality of Life | Post ICU SyndromeFrance
-
University of MelbourneEnrolling by invitationICU Acquired Weakness | Intensive Care Unit Syndrome | Intensive Care Unit Acquired Weakness | Post Intensive Care Unit Syndrome | Post Intensive Care SyndromeAustralia
-
IHU StrasbourgRhythm Diagnostic SystemsRecruitingPost ICU RehabilitationFrance
-
National Taiwan University HospitalCompletedPatients Admitted to the ICU More Than 3 Days Post-onsetTaiwan
-
Fundació Institut de Recerca de l'Hospital de la...CompletedQuality of Life | Chronic Pain | Post ICU SyndromeSpain
-
Kirby MayerNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsRecruitingCritical Illness | Muscle Weakness | ICU Acquired Weakness | Post Intensive Care Unit SyndromeUnited States
Clinical Trials on Medical Record Review - Inpatient Treatment
-
Jena University HospitalUniversity of Leipzig; Technische Universität Dresden; University of Magdeburg; University of Rostock and other collaboratorsCompletedHIV Seropositivity | CD4+ T LymphocytopeniaGermany
-
Member Companies of the Opioid PMR ConsortiumHealthCore, Inc.CompletedOpioid-Related Disorders | Drug Abuse | Opiate Addiction | Narcotic Abuse
-
Samsung Medical CenterCompletedThoracic Aortic SurgeryKorea, Republic of
-
University of Alabama at BirminghamActive, not recruiting
-
Washington University School of MedicineActive, not recruitingHeart Diseases | Virus Diseases | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes | Diabetes Mellitus, Type 1 | Enterovirus Infections | Pregnancy Complications | Heart Defects, Congenital | Viremia | Congenital Heart Disease | Pregnancy in Diabetic | Enterovirus | Prenatal Infection | PrenatalUnited States
-
Ohio State UniversitySelect MedicalCompletedPain | Delirium | Anxiety | Agitation | VentilatorsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Breast Carcinoma | Head and Neck Carcinoma | Lung CarcinomaUnited States
-
Milton S. Hershey Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...RecruitingHyperglycemia | Hypoglycemia | Diabetes | PreDiabetes | Hyperglycemia StressUnited States
-
Dana-Farber Cancer InstituteNational Institute on Aging (NIA)CompletedCovid19 | Advanced Care Planning | Shared Decision Making | Advance Directives | Communication Skills | Video Decision Aids | Natural Language ProcessingUnited States
-
Baylor Research InstituteAmerican Diabetes AssociationCompletedDiabetes MellitusUnited States